Holen Sie sich die Stockscreener-App
114.81
2.20%
-2.58
Handel nachbörslich:
114.86
0.05
+0.04%
Schlusskurs vom Vortag:
$117.39
Offen:
$117.02
24-Stunden-Volumen:
115.33K
Relative Volume:
0.54
Marktkapitalisierung:
$2.62B
Einnahmen:
$249.60M
Nettoeinkommen (Verlust:
$57.73M
KGV:
45.67
EPS:
2.5139
Netto-Cashflow:
$74.47M
1W Leistung:
+2.14%
1M Leistung:
+6.25%
6M Leistung:
+31.57%
1J Leistung:
+35.66%
1-Tages-Spanne:
$114.09
$117.42
1-Wochen-Bereich:
$110.66
$118.01
52-Wochen-Spanne:
$78.01
$118.01
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
114.81 | 2.68B | 249.60M | 57.73M | 74.47M | 2.5139 |
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
LEMAITRE VASCULAR INC ($LMAT) CEO 2025 Pay Revealed - Quiver Quantitative
LeMaitre Vascular (NASDAQ:LMAT) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat
Annex Advisory Services LLC Acquires 13,692 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026 - The Manila Times
LMAT | LeMaitre Vascular, Inc. FinancialsIncome Statement - Quiver Quantitative
LeMaitre Vascular, Inc. to Announce First Quarter 2026 Financial Results on May 5, 2026 - Quiver Quantitative
LeMaitre will post Q1 results after close, then hold a 5 p.m. call - Stock Titan
LeMaitre Vascular : Proxy Card for 2026 Annual Meeting - marketscreener.com
Lemaitre Vascular stock hits all-time high at 116.48 USD By Investing.com - Investing.com Australia
LeMaitre Vascular (NASDAQ:LMAT) Reaches New 1-Year HighWhat's Next? - MarketBeat
Lemaitre Vascular stock hits all-time high at 116.48 USD - Investing.com
LeMaitre Vascular (LMAT) details 2026 board, pay and auditor votes - Stock Titan
LeMaitre Vascular Announces Board Changes and Size Reduction - TipRanks
LeMaitre Vascular director Bridget Ross to step down after annual meeting - Investing.com India
Board reshuffle at LeMaitre Vascular (NASDAQ: LMAT) for 2026 vote - Stock Titan
Sell Signal: Is LeMaitre Vascular Inc a strong candidate for buy and holdMarket Sentiment Review & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Breakout Watch: Is LeMaitre Vascular Inc a top pick in the sector2026 Investor Takeaways & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Liquidity Mapping Around (LMAT) Price Events - Stock Traders Daily
Is LeMaitre Vascular, Inc. (LMAT) a good stock to buy now? - MSN
69,202 Shares in LeMaitre Vascular, Inc. $LMAT Acquired by Tudor Investment Corp ET AL - MarketBeat
LeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference - Sahm
LeMaitre management to speak at Needham virtual healthcare conference - Stock Titan
New Strong Buy Stocks for November 14th - MSN
LMAT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
LeMaitre Vascular (NASDAQ:LMAT) Upgraded at Freedom Capital - Defense World
LMAT SEC FilingsLemaitre Vasculr 10-K, 10-Q, 8-K Forms - Stock Titan
SG Americas Securities LLC Raises Stock Position in LeMaitre Vascular, Inc. $LMAT - marketbeat.com
Gainers Report: Is LeMaitre Vascular Inc a strong candidate for buy and hold2026 EndofMonth & Weekly High Return Stock Forecasts - baoquankhu1.vn
LeMaitre Vascular, Inc. (LMAT): A bull case theory - MSN
Why (LMAT) Price Action Is Critical for Tactical Trading - Stock Traders Daily
[Form 4] LEMAITRE VASCULAR INC Insider Trading Activity - Stock Titan
LeMaitre (NASDAQ: LMAT) director receives dividend equivalent rights awards - Stock Titan
Dividend equivalents boost LeMaitre Vascular (LMAT) director stock awards - Stock Titan
LeMaitre Vascular (LMAT) director granted new dividend equivalent rights - Stock Titan
LeMaitre (NASDAQ: LMAT) director awarded new dividend equivalent rights - Stock Titan
LeMaitre (NASDAQ: LMAT) director awarded dividend equivalent rights - Stock Titan
LeMaitre Vascular (LMAT) president reports grants of dividend equivalent rights - Stock Titan
LeMaitre (LMAT) SVP awarded new dividend equivalent rights grants - stocktitan.net
LeMaitre Vascular (LMAT) CFO granted new dividend equivalent rights - stocktitan.net
LeMaitre Vascular (NASDAQ: LMAT) CEO receives dividend equivalent rights grants - Stock Titan
Why The LeMaitre Vascular (LMAT) Story Is Evolving As Targets Cluster Around US$111 - Yahoo Finance
Is LeMaitre Vascular, Inc. (LMAT) A Good Stock To Buy Now? - Insider Monkey
JPMorgan Chase & Co. Has $10.68 Million Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
LeMaitre Vascular Executive Stock SaleMarch 2026 UpdateNews and Statistics - IndexBox
LeMaitre Vascular, Inc. (LMAT) Stock Forecasts - Yahoo! Finance Canada
LeMaitre Vascular Executive Stock Transaction Analysis - Intellectia AI
A LeMaitre Vascular (LMAT) Insider Sold 2,625 Shares for $285K - Yahoo Finance
LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should Know - Yahoo Finance
LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should Know - The Motley Fool
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.06%
1.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):